1-Dec-2025 3:05 PM CST - Business Wire Simulations Plus Reports Fourth Quarter and Fiscal 2025 Financial Results Simulations Plus, Inc. (Nasdaq: SLP) (Simulations Plus or the Company), a global leader in cheminformatics, biosimulation, clinical operations solutions and medical communications that accelerate biopharma innovation, today reported financial results for its fourth quarter and fiscal 2025, ended August 31, 2025. Fourth Quarter 2025 Financial Highlights (as compared to fourth quarter 2024) Total revenue decreased 6% to $17.5 million Software rev
22-Oct-2025 6:50 AM CST - Business Wire Simulations Plus Announces Preliminary Fiscal Year 2025 Results and Fiscal Year 2026 Guidance Simulations Plus, Inc. (Nasdaq: SLP) (Simulations Plus or the Company), a leading provider of cheminformatics, biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma industry, today announced preliminary results for its fiscal year 2025 and issued preliminary guidance and management outlook for fiscal year 2026 as follows: Fiscal 2025 Preliminary Fiscal 2026 Guidance Revenue
27-Aug-2025 6:50 AM CST - Business Wire Simulations Plus to Participate in Upcoming Investor Conferences Simulations Plus, Inc. (Nasdaq: SLP) (Simulations Plus, SLP), a leading provider of cheminformatics, biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma industry, today announced that Shawn OConnor, Chief Executive Officer, will be participating in the following investor events in September: 2025 Wells Fargo Healthcare Conference Format: Fireside chat and one-on-one meetings Whe
14-Jul-2025 3:05 PM CST - Business Wire Simulations Plus Reports Third Quarter Fiscal 2025 Financial Results Simulations Plus, Inc. (Nasdaq: SLP) (Simulations Plus or the Company), a leading provider of cheminformatics, biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma industry, today reported financial results for its third quarter fiscal 2025, ended May 31, 2025. Third Quarter 2025 Financial Highlights (as compared to third quarter 2024) Total revenue increased 10% to $20.4 million
18-Jun-2025 3:05 PM CST - Business Wire Simulations Plus Announces Rescheduling of Third Quarter Fiscal 2025 Earnings Release and Conference Call Simulations Plus, Inc. (Nasdaq: SLP) (Simulations Plus or the Company), a leading provider of cheminformatics, biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma industry, today announced that it has rescheduled the release of its financial results and conference call for the third fiscal quarter ended May 31, 2025, which had previously been scheduled for July 2, 2025. The Compa
11-Jun-2025 3:30 PM CST - Business Wire Simulations Plus Announces Preliminary Third Quarter Fiscal 2025 Revenue Simulations Plus, Inc. (Nasdaq: SLP) (Simulations Plus or the Company), a leading provider of cheminformatics, biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma industry, today announced preliminary revenue for its third fiscal quarter and updated its full year 2025 revenue guidance. The Company expects to report third quarter fiscal 2025 revenue in the range of between $19 mil
3-Apr-2025 3:05 PM CST - Business Wire Simulations Plus Reports Second Quarter Fiscal 2025 Financial Results Simulations Plus, Inc. (Nasdaq: SLP) (Simulations Plus), a leading provider of cheminformatics, biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma industry, today reported financial results for its second quarter fiscal 2025, ended February 28, 2025. Second Quarter 2025 Financial Highlights (as compared to second quarter 2024) Total revenue increased 23% to $22.4 million Software
20-Mar-2025 6:00 AM CST - Business Wire Simulations Plus Announces Second Quarter Fiscal Year 2025 Earnings and Conference Call Date Simulations Plus, Inc. (Nasdaq: SLP) (Simulations Plus, SLP), a leading provider of cheminformatics, biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma industry, today announced that it will report second quarter fiscal 2025 financial results after the market close on Thursday, April 3, 2025. Management will host a conference call that same day at 5:00 p.m. Eastern Time to discu
10-Mar-2025 6:00 AM CST - Business Wire Simulations Plus to Present at the KeyBanc Capital Markets Virtual Healthcare Investor Forum Simulations Plus, Inc. (Nasdaq: SLP) (Simulations Plus, SLP), a leading provider of cheminformatics, biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma industry, today announced that Shawn OConnor, Chief Executive Officer, will be participating in a fireside chat at the KeyBanc Capital Markets Virtual Healthcare Investor Forum on Tuesday, March 18, 2025, at 2:15 p.m. Eastern Ti
1-Dec-2025 3:05 PM CST - Business Wire Simulations Plus Reports Fourth Quarter and Fiscal 2025 Financial Results Simulations Plus, Inc. (Nasdaq: SLP) (Simulations Plus or the Company), a global leader in cheminformatics, biosimulation, clinical operations solutions and medical communications that accelerate biopharma innovation, today reported financial results for its fourth quarter and fiscal 2025, ended August 31, 2025. Fourth Quarter 2025 Financial Highlights (as compared to fourth quarter 2024) Total revenue decreased 6% to $17.5 million Software rev
22-Oct-2025 6:50 AM CST - Business Wire Simulations Plus Announces Preliminary Fiscal Year 2025 Results and Fiscal Year 2026 Guidance Simulations Plus, Inc. (Nasdaq: SLP) (Simulations Plus or the Company), a leading provider of cheminformatics, biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma industry, today announced preliminary results for its fiscal year 2025 and issued preliminary guidance and management outlook for fiscal year 2026 as follows: Fiscal 2025 Preliminary Fiscal 2026 Guidance Revenue
27-Aug-2025 6:50 AM CST - Business Wire Simulations Plus to Participate in Upcoming Investor Conferences Simulations Plus, Inc. (Nasdaq: SLP) (Simulations Plus, SLP), a leading provider of cheminformatics, biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma industry, today announced that Shawn OConnor, Chief Executive Officer, will be participating in the following investor events in September: 2025 Wells Fargo Healthcare Conference Format: Fireside chat and one-on-one meetings Whe
14-Jul-2025 3:05 PM CST - Business Wire Simulations Plus Reports Third Quarter Fiscal 2025 Financial Results Simulations Plus, Inc. (Nasdaq: SLP) (Simulations Plus or the Company), a leading provider of cheminformatics, biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma industry, today reported financial results for its third quarter fiscal 2025, ended May 31, 2025. Third Quarter 2025 Financial Highlights (as compared to third quarter 2024) Total revenue increased 10% to $20.4 million
18-Jun-2025 3:05 PM CST - Business Wire Simulations Plus Announces Rescheduling of Third Quarter Fiscal 2025 Earnings Release and Conference Call Simulations Plus, Inc. (Nasdaq: SLP) (Simulations Plus or the Company), a leading provider of cheminformatics, biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma industry, today announced that it has rescheduled the release of its financial results and conference call for the third fiscal quarter ended May 31, 2025, which had previously been scheduled for July 2, 2025. The Compa
11-Jun-2025 3:30 PM CST - Business Wire Simulations Plus Announces Preliminary Third Quarter Fiscal 2025 Revenue Simulations Plus, Inc. (Nasdaq: SLP) (Simulations Plus or the Company), a leading provider of cheminformatics, biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma industry, today announced preliminary revenue for its third fiscal quarter and updated its full year 2025 revenue guidance. The Company expects to report third quarter fiscal 2025 revenue in the range of between $19 mil
3-Apr-2025 3:05 PM CST - Business Wire Simulations Plus Reports Second Quarter Fiscal 2025 Financial Results Simulations Plus, Inc. (Nasdaq: SLP) (Simulations Plus), a leading provider of cheminformatics, biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma industry, today reported financial results for its second quarter fiscal 2025, ended February 28, 2025. Second Quarter 2025 Financial Highlights (as compared to second quarter 2024) Total revenue increased 23% to $22.4 million Software
20-Mar-2025 6:00 AM CST - Business Wire Simulations Plus Announces Second Quarter Fiscal Year 2025 Earnings and Conference Call Date Simulations Plus, Inc. (Nasdaq: SLP) (Simulations Plus, SLP), a leading provider of cheminformatics, biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma industry, today announced that it will report second quarter fiscal 2025 financial results after the market close on Thursday, April 3, 2025. Management will host a conference call that same day at 5:00 p.m. Eastern Time to discu
10-Mar-2025 6:00 AM CST - Business Wire Simulations Plus to Present at the KeyBanc Capital Markets Virtual Healthcare Investor Forum Simulations Plus, Inc. (Nasdaq: SLP) (Simulations Plus, SLP), a leading provider of cheminformatics, biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma industry, today announced that Shawn OConnor, Chief Executive Officer, will be participating in a fireside chat at the KeyBanc Capital Markets Virtual Healthcare Investor Forum on Tuesday, March 18, 2025, at 2:15 p.m. Eastern Ti
